GlassScriptPhysician profile
James L Pyle
NPI 1508962150
$275.37
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.17 · 2020: $21.34 · 2021: $95.81 · 2022: $70.13 · 2023: $27.69 · 2024: $40.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $49.04 | 2021 | |
| Abbvie INC. | $46.74 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.91 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $24.76 | 2024 | Spectacle Lenses, Contact Lens |
| Glaxosmithkline, LLC. | $21.62 | 2022-2023 | Pediarix, Bexsero, Shingrix |
| Alcon Vision LLC | $21.34 | 2020 | |
| Bausch & Lomb Americas INC. | $18.63 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.49 | 2023 | |
| Exact Sciences Corporation | $15.47 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $13.21 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.